Therefore, each year there is an increasing trend of NP-based therapies being approved by governmental medicine regulatory agencies such as the US Food and Drug Administration (FDA) [ 11 , 12 ] or the European Medicines Agency (EMA) [ 13 , 14 ].
← all excerpts
Atypical Renal Clearance of Nanoparticles Larger Than the Kidney Filtration Threshold.
1
—
—